Stock Research for SGEN

SGEN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SGEN Stock Chart & Research Data

The SGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SGEN Due diligence Resources & Stock Charts

The SGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SGEN Detailed Price Forecast - CNN Money CNN View SGEN Detailed Summary - Google Finance
Yahoo View SGEN Detailed Summary - Yahoo! Finance Zacks View SGEN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SGEN Trends & Analysis - Trade-Ideas Barrons View SGEN Major Holders - Barrons
NASDAQ View SGEN Call Transcripts - NASDAQ Seeking View SGEN Breaking News & Analysis - Seeking Alpha
Spotlight View SGEN Annual Report - CompanySpotlight.com OTC Report View SGEN OTC Short Report - OTCShortReport.com
TradeKing View SGEN Fundamentals - TradeKing Charts View SGEN SEC Filings - Bar Chart
WSJ View Historical Prices for SGEN - The WSJ Morningstar View Performance/Total Return for SGEN - Morningstar
MarketWatch View the Analyst Estimates for SGEN - MarketWatch CNBC View the Earnings History for SGEN - CNBC
StockMarketWatch View the SGEN Earnings - StockMarketWatch MacroAxis View SGEN Buy or Sell Recommendations - MacroAxis
Bullish View the SGEN Bullish Patterns - American Bulls Short Pains View SGEN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SGEN Stock Mentions - StockTwits PennyStocks View SGEN Stock Mentions - PennyStockTweets
Twitter View SGEN Stock Mentions - Twitter Invest Hub View SGEN Investment Forum News - Investor Hub
Yahoo View SGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View SGEN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SGEN - SECform4.com Insider Cow View Insider Transactions for SGEN - Insider Cow
CNBC View SGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SGEN - OTC Markets
Yahoo View Insider Transactions for SGEN - Yahoo! Finance NASDAQ View Institutional Holdings for SGEN - NASDAQ


Stock Charts

FinViz View SGEN Stock Insight & Charts - FinViz.com StockCharts View SGEN Investment Charts - StockCharts.com
BarChart View SGEN Stock Overview & Charts - BarChart Trading View View SGEN User Generated Charts - Trading View




Latest Financial News for SGEN


Understanding Seattle Genetics’ Operational Performance
Posted on Tuesday December 11, 2018

How's Seattle Genetics Positioned? For fiscal 2018 and 2019, Seattle Genetics’ gross margins are expected at 88.54% and 88.58%, respectively, as compared with gross margins of 88.78% for fiscal 2017. In comparison, the fiscal 2018 gross margins of peers Amgen (AMGN), Gilead Sciences (GILD), and Eli Lilly & Co (LLY) are expected at 85.83%, 84.81%, and 76.05%, respectively.


What Seattle Genetics’ Bottom-Line Trend Indicates
Posted on Tuesday December 11, 2018

Seattle Genetics (SGEN) had generated net investment and other income of $82.22 million in the third quarter of 2017. In the third quarter of 2018, on the other hand, it incurred net investment and other loss of $21.87 million.


How’s Seattle Genetics Positioned?
Posted on Tuesday December 11, 2018

How's Seattle Genetics Positioned? Seattle Genetics (SGEN) is a biotechnology company with a focus on developing and bringing to market targeted therapies for cancer. Seattle Genetics generated total revenues of $169.42 million in the third quarter of 2018 as compared with $135.29 million in the comparable period of 2017.


Report: Developing Opportunities within Covanta Holding, Zscaler, Avaya, Seattle Genetics, Viad, and Canada Goose — Future Expectations, Projections Moving into 2019
Posted on Monday December 10, 2018

NEW YORK, Dec. 10, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.